KLF4 Inhibits the Activation of Human Hepatic Stellate Cell In Vitro

Abstract

Objective

Hepatic stellate cells (HSCs) play a crucial role in liver fibrosis. Early-stage liver fibrosis is reversible and intimately associated with the state of HSCs. Kruppel-like factor 4 (KLF4) plays a pivotal role in a wide array of physiological and pathological processes. This study aimed to investigate the effect of KLF4 on the proliferation, apoptosis and phenotype of quiescent HSCs

Methods

We designed a KLF4 lentiviral vector and a KLF4 siRNA lentiviral vector, to upregulate and silence KLF4 expression in human HSC LX-2 cells via transfection. Cell proliferation was assessed using the CCK-8 assay. Flow cytometry was used to detect the cell cycle distribution and apoptosis rate. Western blotting was used to determine the levels of some quiescence and activation markers of HSCs

Results

Overexpression of KLF4 significantly increased the levels of E-cadherin and ZO-1, which are quiescent HSC markers, while significantly decreased the levels of N-cadherin and a-SMA, known activated HSC markers. In contrast, cell proliferation and apoptosis rates were elevated in LX-2 cells in which KLF4 expression was silenced

Conclusion

KLF4 inhibits the proliferation and activation of human LX-2 HSCs. It might be a key regulatory protein in the maintenance of HSC quiescence and may serve as a target for the inhibition of hepatic fibrosis

References

[1] Suarez-CuencaJA, Chagoyad S V, Aranda-FraustroA, et al.. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells. Exp Biol Med, 2008, 233(7): 827-839

[2] ShieldsJM, ChristyRJ, YangVW. Identification and characterization of a gene encoding a gut-enriched Krueppellike factor expressed during growth arrest. J Biol Chem, 1996, 271(33): 20009-20017

[3] SakoT, YuspaSH, HeraldCL, et al.. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res, 1987, 47(20): 5445-5450

[4] AnthonyB, AllenJT, LiYS, et al.. Hepatic stellate cells and parasite-induced liver fibrosis. Parasites Vectors, 2010, 3: 60

[5] Garrett-SinhaLA, EberspaecherH, SeldinMF, et al.. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem, 1996, 271(49): 31384-31390

[6] ZhangQ, PanRR, WuYT, et al.. MicroRNA-146a Promotes Embryonic Stem Cell Differentiation towards Vascular Smooth Muscle Cells through Regulation of Kruppel-like Factor 4. Curr Med Sci, 2023, 43(2): 223-231

[7] XueYK, TanJ, DouDW, et al.. Effect of Kruppel-like factor 4 on Notch pathway in hepatic stellate cells. J Huazhong Univ Sci Technolog Med Sci, 2016, 36(6): 811-816

[8] MoreiraRK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med, 2007, 131(11): 1728-1734

[9] GuyotC, LepreuxS, CombeC, et al.. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol, 2006, 38(2): 135-151

[10] ForbesSJ, ParolaM. Liver fibrogenic cells. Best Pract Res Clin Gastroenterol, 2011, 25(2): 207-217

[11] GeorgeJ, RoulotD, KotelianskyVE, et al.. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A, 1999, 96(22): 12719-12724

[12] GeorgeJ, WangSS, SevcsikAM, et al.. Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform. Am J Pathol, 2000, 156(1): 115-124

[13] ZhaoQ, QinCY, ZhaoZH, et al.. Epigenetic Modifications in Hepatic Stellate Cells Contribute to Liver Fibrosis. Tohoku J Exp Med, 2013, 229(1): 35-43

[14] WellsRG, KruglovE, DranoffJA. Autocrine release of TGFbeta by portal fibroblasts regulates cell growth. FEBS Lett, 2004, 559(1–3): 107-110

[15] JhandierMN, KruglovEA, LavoieEG, et al.. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem, 2005, 280(24): 22986-22992

[16] KisselevaT, UchinamiH, FeirtN, et al.. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol, 2006, 45(3): 429-438

[17] ForbesSJ, RussoFP, ReyV, et al.. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology, 2004, 126(4): 955-963

[18] ZeisbergM, YangC, MartinoM, et al.. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem, 2007, 282(32): 23337-23347

[19] RockeyDC, HoussetCN, FriedmanSL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest, 1993, 92(4): 1795-1804

[20] MaherJJ, ZiaS, TzagarakisC. Acetaldehyde-induced stimulation of collagen synthesis and gene expression is dependent on conditions of cell culture: studies with rat lipocytes and fibroblasts. Alcohol Clin Exp Res, 1994, 18(2): 403-409

[21] BlomhoffR, WakeK. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J, 1991, 5(3): 271-277

[22] TsukamotoH. Adipogenic phenotype of hepatic stellate cells. Alcohol Clin Exp Res, 2005, 29: 132S-133S

[23] SenooH, YoshikawaK, MoriiM, et al.. Hepatic stellate cell ^(vitamin A-storing cell) and its relative — past, present and future. Cell Biol Int, 2010, 34(12): 1247-1272

[24] MinarJ. Worldwide distribution of mosquitoes in the subfamily Anophelinae and its relation to the transmission of malaria. Cesk Epidemiol Mikrobiol Imunol, 1987, 36(4): 244-251

[25] Ghiassi-NejadZ, FriedmanSL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol, 2008, 2(6): 803-816

[26] FriedmanSL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem, 2000, 275(4): 2247-2250

[27] EngFJ, FriedmanSL. Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest Liver Physiol, 2000, 279(1): G7-G11

[28] LeeUE, FriedmanSL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol, 2011, 25(2): 195-206

[29] NovoE, CannitoS, PaternostroC, et al.. Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys, 2014, 548: 20-37

[30] GressnerAM, WeiskirchenR, BreitkopfK, et al.. Roles of TGF-beta in hepatic fibrosis. Front Biosci, 2002, 7: d793-d807

[31] DomitrovićR, JakovacH, TomacJ, et al.. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol Appl Pharmacol, 2009, 241(3): 311-321

[32] RamachandranP, IredaleJP. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol, 2012, 56(6): 1417-1419

[33] SchnaperHW. Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis. Pediatr Nephrol, 1995, 9(1): 104-111

[34] HeymannF, TrautweinC, TackeF. Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy Drug Targets, 2009, 8(4): 307-318

[35] GonzalezSA, FielMI, SaukJ, et al.. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J Viral Hepat, 2009, 16(2): 141-148

[36] KisselevaT, CongM, PaikY, et al.. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA, 2012, 109(24): 9448-9453

[37] WangY, LiJ, WangX, et al.. Hepatic stellate cells, liver innate immunity, and hepatitis C virus. J Gastroenterol Hepatol, 2013, 28: 112-115